Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,055.84 +37.45 (+0.75%) Dow
38,128.27 +224.98 (+0.59%) Nasdaq
15,761.86 +156.38 (+1.00%) Bitcoin USD
58,639.37 +1,086.09 (+1.89%) CMC Crypto 200
1,265.10 -5.64 (-0.44%)
Baxter International Inc. (BAX)
| Previous close | 40.34 |
| Open | 40.13 |
| Bid | 0.00 x 800 |
| Ask | 40.25 x 1000 |
| Day's range | 38.31 - 39.15 |
| 52-week range | 31.01 - 50.21 |
| Volume | |
| Avg. volume | 3,643,913 |
| Market cap | 19.513B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.16 (2.88%) |
| Ex-dividend date | 29 Feb 2024 |
| 1y target est | N/A |
- Business Wire
Baxter Reports First-Quarter 2024 Results
DEERFIELD, Ill., May 02, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
- Business Wire
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
DEERFIELD, Ill., April 11, 2024--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S.
- Business Wire
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
DEERFIELD, Ill., April 10, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I215737 to pre-register for the call and receive the call information.
